According to a new report by Transparency Market Research released this week, the implantable cardiac monitoring market is booming, particularly in the US and Canada and is expected to reach $1.6 Bn by 2031.

Cardiac arrythmias like atrial fibrillation are on the rise and being able to quickly identify changes in heart rhythms can make a world of difference to patients. Luckily, as implantable medical devices become more sophisticated and sensitive, patients who suffer (or could potentially suffer) can be monitored and assisted much quicker using these remote monitoring devices, such as implantable cardiac monitors. North America is expected to continue to be the fastest growing market for these devices because it accounted for the majority of the market in 2022.

Key drivers of adoption would be:

• Increasing number of people are developing these heart issues
• Technological advancements are getting devices to miniaturize and become more sophisticated including battery life improvements
• Reimbursement policies make it easier for clinicians and patients to adopt implantable cardiac monitoring devices

Key industry players that Transparency Market Research identified are:

• Medtronic
• Abott
• Biotronik
• Angel Medical Systems Inc.
• Vectorious
• Boston Scientific Corporation
• Biosense Webster Inc.

For mor information, visit: Transparency Market Research.

Extending the edge of hospital networks to device-enabled patients, the threat landscape should be treated with the utmost care, especially as more implantable devices come online.